- Home
- Publications
- Publication Search
- Publication Details
Title
Inhibitors of PARP: Number crunching and structure gazing
Authors
Keywords
-
Journal
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Volume 119, Issue 11, Pages -
Publisher
Proceedings of the National Academy of Sciences
Online
2022-03-09
DOI
10.1073/pnas.2121979119
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Linking DNA repair and cell cycle progression through serine ADP-ribosylation of histones
- (2022) Julien Brustel et al. Nature Communications
- Identifying Poly(ADP-ribose)-Binding Proteins with Photoaffinity-Based Proteomics
- (2021) Morgan Dasovich et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- HPF1 remodels the active site of PARP1 to enable the serine ADP-ribosylation of histones
- (2021) Fa-Hui Sun et al. Nature Communications
- Histone Parylation factor 1 contributes to the inhibition of PARP1 by cancer drugs
- (2021) Johannes Rudolph et al. Nature Communications
- HPF1 and nucleosomes mediate a dramatic switch in activity of PARP1 from polymerase to hydrolase
- (2021) Johannes Rudolph et al. eLife
- Targeting the nucleotide salvage factor DNPH1 sensitizes BRCA-deficient cells to PARP inhibitors
- (2021) Kasper Fugger et al. SCIENCE
- SMARCAD1-mediated active replication fork stability maintains genome integrity
- (2021) Calvin Shun Yu Lo et al. Science Advances
- PARP1: Structural insights and pharmacological targets for inhibition
- (2021) Jacob O. Spiegel et al. DNA REPAIR
- Serine-linked PARP1 auto-modification controls PARP inhibitor response
- (2021) Evgeniia Prokhorova et al. Nature Communications
- The BRCT domain of PARP1 binds intact DNA and mediates intrastrand transfer
- (2021) Johannes Rudolph et al. MOLECULAR CELL
- HPF1 completes the PARP active site for DNA damage-induced ADP-ribosylation
- (2020) Marcin J. Suskiewicz et al. NATURE
- Probing the Conformational Changes Associated with DNA Binding to PARP1
- (2020) Johannes Rudolph et al. BIOCHEMISTRY
- Structural basis for allosteric PARP-1 retention on DNA breaks
- (2020) Levani Zandarashvili et al. SCIENCE
- Real-time monitoring of PARP1-dependent PARylation by ATR-FTIR spectroscopy
- (2020) Annika Krüger et al. Nature Communications
- Therapeutic Potential of Combining PARP Inhibitor and Immunotherapy in Solid Tumors
- (2020) Praveen Vikas et al. Frontiers in Oncology
- Progress and outlook in studying the substrate specificities of PARPs and related enzymes
- (2020) Marcin J. Suskiewicz et al. FEBS Journal
- How to measure and evaluate binding affinities
- (2020) Inga Jarmoskaite et al. eLife
- The ups and downs of Poly(ADP-ribose) Polymerase-1 inhibitors in cancer therapy–Current progress and future direction
- (2020) Yue Zhao et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Bridging of DNA breaks activates PARP2–HPF1 to modify chromatin
- (2020) Silvija Bilokapic et al. NATURE
- Poly(ADP-ribose) polymerase inhibition: past, present and future
- (2020) Nicola J. Curtin et al. NATURE REVIEWS DRUG DISCOVERY
- Defective ALC1 nucleosome remodeling confers PARPi sensitization and synthetic lethality with HRD
- (2020) Graeme Hewitt et al. MOLECULAR CELL
- The chromatin remodeler ALC1 underlies resistance to PARP inhibitor treatment
- (2020) Szilvia Juhász et al. Science Advances
- PARP Inhibitors: Extending Benefit Beyond BRCA-Mutant Cancers
- (2019) Patrick G. Pilié et al. CLINICAL CANCER RESEARCH
- PARP Inhibitor Resistance: A Tug-of-War in BRCA-Mutated Cells
- (2019) Sylvie M. Noordermeer et al. TRENDS IN CELL BIOLOGY
- A rapid fluorescent method for the real-time measurement of poly(ADP-ribose) polymerase 1 activity
- (2018) T.A. Kurgina et al. ANALYTICAL BIOCHEMISTRY
- NAD+ analog reveals PARP-1 substrate-blocking mechanism and allosteric communication from catalytic center to DNA-binding domains
- (2018) Marie-France Langelier et al. Nature Communications
- Coupling bimolecular PARylation biosensors with genetic screens to identify PARylation targets
- (2018) Dragomir B. Krastev et al. Nature Communications
- Serine is the major residue for ADP-ribosylation upon DNA damage
- (2018) Luca Palazzo et al. eLife
- CRISPR screens identify genomic ribonucleotides as a source of PARP-trapping lesions
- (2018) Michal Zimmermann et al. NATURE
- PARP2 mediates branched poly ADP-ribosylation in response to DNA damage
- (2018) Qian Chen et al. Nature Communications
- Poly(ADP-ribose) polymerase 1 searches DNA via a ‘monkey bar’ mechanism
- (2018) Johannes Rudolph et al. eLife
- PARP family enzymes: regulation and catalysis of the poly(ADP-ribose) posttranslational modification
- (2018) Marie-France Langelier et al. CURRENT OPINION IN STRUCTURAL BIOLOGY
- PARP1 Trapping by PARP Inhibitors Drives Cytotoxicity in Both Cancer Cells and Healthy Bone Marrow
- (2018) Todd A. Hopkins et al. MOLECULAR CANCER RESEARCH
- PARP inhibitors in ovarian cancer
- (2018) Elisena Franzese et al. CANCER TREATMENT REVIEWS
- Risks of Breast, Ovarian, and Contralateral Breast Cancer for BRCA1 and BRCA2 Mutation Carriers
- (2017) Karoline B. Kuchenbaecker et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Serine ADP-Ribosylation Depends on HPF1
- (2017) Juan José Bonfiglio et al. MOLECULAR CELL
- PARP inhibitors: Synthetic lethality in the clinic
- (2017) Christopher J. Lord et al. SCIENCE
- Structural Basis for Potency and Promiscuity in Poly(ADP-ribose) Polymerase (PARP) and Tankyrase Inhibitors
- (2016) Ann-Gerd Thorsell et al. JOURNAL OF MEDICINAL CHEMISTRY
- Non-catalytic Roles for XPG with BRCA1 and BRCA2 in Homologous Recombination and Genome Stability
- (2016) Kelly S. Trego et al. MOLECULAR CELL
- HPF1/C4orf27 Is a PARP-1-Interacting Protein that Regulates PARP-1 ADP-Ribosylation Activity
- (2016) Ian Gibbs-Seymour et al. MOLECULAR CELL
- Laying a trap to kill cancer cells: PARP inhibitors and their mechanisms of action
- (2016) Y. Pommier et al. Science Translational Medicine
- Characterization of the DNA dependent activation of human ARTD2/PARP2
- (2016) Ezeogo Obaji et al. Scientific Reports
- Mechanistic Dissection of PARP1 Trapping and the Impact on In Vivo Tolerability and Efficacy of PARP Inhibitors
- (2015) T. A. Hopkins et al. MOLECULAR CANCER RESEARCH
- Biology of Poly(ADP-Ribose) Polymerases: The Factotums of Cell Maintenance
- (2015) Peter Bai MOLECULAR CELL
- Structures and Mechanisms of Enzymes Employed in the Synthesis and Degradation of PARP-Dependent Protein ADP-Ribosylation
- (2015) Eva Barkauskaite et al. MOLECULAR CELL
- Structural Basis of Detection and Signaling of DNA Single-Strand Breaks by Human PARP-1
- (2015) Sebastian Eustermann et al. MOLECULAR CELL
- PARP-1 Activation Requires Local Unfolding of an Autoinhibitory Domain
- (2015) Jennine M. Dawicki-McKenna et al. MOLECULAR CELL
- DNA-Repair Defects and Olaparib in Metastatic Prostate Cancer
- (2015) Joaquin Mateo et al. NEW ENGLAND JOURNAL OF MEDICINE
- Readers of poly(ADP-ribose): designed to be fit for purpose
- (2015) Federico Teloni et al. NUCLEIC ACIDS RESEARCH
- Poly(ADP-ribose) polymerases in double-strand break repair: Focus on PARP1, PARP2 and PARP3
- (2014) Carole Beck et al. EXPERIMENTAL CELL RESEARCH
- Downfall of Iniparib: A PARP Inhibitor That Doesn't Inhibit PARP After All
- (2014) G. Sinha JNCI-Journal of the National Cancer Institute
- Automodification switches PARP-1 function from chromatin architectural protein to histone chaperone
- (2014) U. M. Muthurajan et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Family-wide analysis of poly(ADP-ribose) polymerase activity
- (2014) Sejal Vyas et al. Nature Communications
- BMN 673, a Novel and Highly Potent PARP1/2 Inhibitor for the Treatment of Human Cancers with DNA Repair Deficiency
- (2013) Y. Shen et al. CLINICAL CANCER RESEARCH
- Stereospecific PARP Trapping by BMN 673 and Comparison with Olaparib and Rucaparib
- (2013) J. Murai et al. MOLECULAR CANCER THERAPEUTICS
- Trapping of PARP1 and PARP2 by Clinical PARP Inhibitors
- (2012) J. Murai et al. CANCER RESEARCH
- PaxDb, a Database of Protein Abundance Averages Across All Three Domains of Life
- (2012) M. Wang et al. MOLECULAR & CELLULAR PROTEOMICS
- Increased PARP-1 Association with DNA in Alkylation Damaged, PARP-Inhibited Mouse Fibroblasts
- (2012) P. S. Kedar et al. MOLECULAR CANCER RESEARCH
- Systematic identification of genomic markers of drug sensitivity in cancer cells
- (2012) Mathew J. Garnett et al. NATURE
- Family-wide chemical profiling and structural analysis of PARP and tankyrase inhibitors
- (2012) Elisabet Wahlberg et al. NATURE BIOTECHNOLOGY
- New insights into the molecular and cellular functions of poly(ADP-ribose) and PARPs
- (2012) Bryan A. Gibson et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Genomics of Drug Sensitivity in Cancer (GDSC): a resource for therapeutic biomarker discovery in cancer cells
- (2012) Wanjuan Yang et al. NUCLEIC ACIDS RESEARCH
- Loss of 53BP1 Causes PARP Inhibitor Resistance in Brca1 -Mutated Mouse Mammary Tumors
- (2012) Janneke E. Jaspers et al. Cancer Discovery
- The underlying mechanism for the PARP and BRCA synthetic lethality: Clearing up the misunderstandings
- (2011) Thomas Helleday Molecular Oncology
- Targeting homologous recombination repair defects in cancer
- (2010) Bastiaan Evers et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Parthanatos, a messenger of death
- (2009) Karen Kate David Frontiers in Bioscience-Landmark
- Discovery and SAR of 2-(1-propylpiperidin-4-yl)-1H-benzimidazole-4-carboxamide: A potent inhibitor of poly(ADP-ribose) polymerase (PARP) for the treatment of cancer
- (2008) Thomas D. Penning et al. BIOORGANIC & MEDICINAL CHEMISTRY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now